Sfoglia per Autore
Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells
2002-01-01 Tentori, L; Portarena, I; Torino, F; Scerrati, M; Navarra, P; Graziani, G
A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report
2002-01-01 Aquino, A; Prete, S; Balduzzi, A; Fossile, E; Formica, V; Torino, F; Bonmassar, L; Di Giacomo, A; Cappelletti, D; Cardillo, A; Graziani, G
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro
2003-01-01 Turriziani, M; Di Giacomo, A; Cardillo, A; Torino, F; Tentori, L; Nasuti, P; Massara, M; Roselli, M; Bonmassar, E; DE VECCHIS, L
Unusual sites of metastatic malignancy: case 1. Cardiac metastasis in hepatocellular carcinoma.
2004-01-01 Longo, R; Mocini, D; Santini, M; Giannantoni, P; Carillio, G; Torino, F; Auriti, A; Marcello, R; Lanzi, G; Cortese, F; Gasparini, G
Therapy of breast cancer with molecular targeting agents.
2005-01-01 Gasparini, G; Longo, R; Torino, F; Morabito, A
Failure of a cetuximab/bevacizumab schedule in a patient with metastatic desmoplastic small round-cell tumour refractory to chemotherapy.
2005-01-01 Longo, R; Torino, F; Morabito, A; Amici, S; Gattuso, D; Manente, L; Gasparini, G
Tailored therapy of colorectal cancer: results, challenges and future directions.
2005-01-01 Gasparini, G; Longo, R; Torino, F; Barone, C; Toffoli, G
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer.
2005-01-01 Gasparini, G; Gattuso, D; Morabito, A; Longo, R; Torino, F; Sarmiento, R; Vitale, S; Gamucci, T; Mariani, L
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer.
2006-01-01 Gasparini, G; Gion, M; Mariani, L; Papaldo, P; Crivellari, D; Filippelli, G; Morabito, A; Silingardi, V; Torino, F; Spada, A; Zancan, M; De Sio, L; Caputo, A; Cognetti, F; Lambiase, A; Amadori, D
Is tailored therapy feasible in oncology?
2006-01-01 Gasparini, G; Longo, R; Torino, F; Gattuso, D; Morabito, A; Toffoli, G
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer.
2006-01-01 Morabito, A; Longo, R; Gattuso, D; Carillio, G; Massaccesi, C; Mariani, L; Bonginelli, P; Amici, S; De Sio, L; Fanelli, M; Torino, F; Bonsignori, M; Gasparini, G
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience
2006-03-01 Correale, P; Cusi, M; Micheli, L; Nencini, C; Del Vecchio, M; Torino, F; Aquino, A; Bonmassar, E; Francini, G; Giorgi, G
Focus on Fotemustine
2006-12-01 De Rossi, A; Rossi, L; Laudisi, A; Sini, V; Toppo, L; Marchesi, F; Tortorelli, G; Leti, M; Turriziani, M; Aquino, A; Bonmassar, E; DE VECCHIS, L; Torino, F
Skin acrometastases in squamous cell carcinoma of the tongue.
2007-01-01 Longo, R; Torino, F; Castellana, M; Amici, S; Verì, A; Cacciamani, F; Gasparini, G; Lanzi, G
Targeted therapy of breast cancer.
2007-01-01 Longo, R; Torino, F; Gasparini, G
Prognostic and Predictive Significance of Surrogate Biomarkers of Angiogenesis.
2008-01-01 Longo, R; Torino, F; Gasparini, G
Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all?
2008-01-01 Bazuro, G; Torino, F; Gasparini, G; Capurso, L
Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy
2008-01-01 Prete, S; Turriziani, M; Massara, M; De Rossi, A; Correale, P; DE VECCHIS, L; Torino, F; Bonmassar, L; Aquino, A
Is hypothyroidism a clinically relevant toxicity of tyrosine kinase inhibitors?
2009-01-01 Torino, F; Corsello, S; Longo, R; Barnabei, A; Gasparini, G
Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy.
2009-01-01 Torino, F; Corsello, S; Longo, R; Barnabei, A; Gasparini, G
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2002 | Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells | Tentori, L; Portarena, I; Torino, F; Scerrati, M; Navarra, P; Graziani, G | Articolo su rivista | |
1-gen-2002 | A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report | Aquino, A; Prete, S; Balduzzi, A; Fossile, E; Formica, V; Torino, F; Bonmassar, L; Di Giacomo, A; Cappelletti, D; Cardillo, A; Graziani, G | Articolo su rivista | |
1-gen-2003 | Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro | Turriziani, M; Di Giacomo, A; Cardillo, A; Torino, F; Tentori, L; Nasuti, P; Massara, M; Roselli, M; Bonmassar, E; DE VECCHIS, L | Articolo su rivista | |
1-gen-2004 | Unusual sites of metastatic malignancy: case 1. Cardiac metastasis in hepatocellular carcinoma. | Longo, R; Mocini, D; Santini, M; Giannantoni, P; Carillio, G; Torino, F; Auriti, A; Marcello, R; Lanzi, G; Cortese, F; Gasparini, G | Articolo su rivista | |
1-gen-2005 | Therapy of breast cancer with molecular targeting agents. | Gasparini, G; Longo, R; Torino, F; Morabito, A | Articolo su rivista | |
1-gen-2005 | Failure of a cetuximab/bevacizumab schedule in a patient with metastatic desmoplastic small round-cell tumour refractory to chemotherapy. | Longo, R; Torino, F; Morabito, A; Amici, S; Gattuso, D; Manente, L; Gasparini, G | Articolo su rivista | |
1-gen-2005 | Tailored therapy of colorectal cancer: results, challenges and future directions. | Gasparini, G; Longo, R; Torino, F; Barone, C; Toffoli, G | Articolo su rivista | |
1-gen-2005 | Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer. | Gasparini, G; Gattuso, D; Morabito, A; Longo, R; Torino, F; Sarmiento, R; Vitale, S; Gamucci, T; Mariani, L | Articolo su rivista | |
1-gen-2006 | Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer. | Gasparini, G; Gion, M; Mariani, L; Papaldo, P; Crivellari, D; Filippelli, G; Morabito, A; Silingardi, V; Torino, F; Spada, A; Zancan, M; De Sio, L; Caputo, A; Cognetti, F; Lambiase, A; Amadori, D | Articolo su rivista | |
1-gen-2006 | Is tailored therapy feasible in oncology? | Gasparini, G; Longo, R; Torino, F; Gattuso, D; Morabito, A; Toffoli, G | Articolo su rivista | |
1-gen-2006 | Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer. | Morabito, A; Longo, R; Gattuso, D; Carillio, G; Massaccesi, C; Mariani, L; Bonginelli, P; Amici, S; De Sio, L; Fanelli, M; Torino, F; Bonsignori, M; Gasparini, G | Articolo su rivista | |
1-mar-2006 | Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience | Correale, P; Cusi, M; Micheli, L; Nencini, C; Del Vecchio, M; Torino, F; Aquino, A; Bonmassar, E; Francini, G; Giorgi, G | Articolo su rivista | |
1-dic-2006 | Focus on Fotemustine | De Rossi, A; Rossi, L; Laudisi, A; Sini, V; Toppo, L; Marchesi, F; Tortorelli, G; Leti, M; Turriziani, M; Aquino, A; Bonmassar, E; DE VECCHIS, L; Torino, F | Articolo su rivista | |
1-gen-2007 | Skin acrometastases in squamous cell carcinoma of the tongue. | Longo, R; Torino, F; Castellana, M; Amici, S; Verì, A; Cacciamani, F; Gasparini, G; Lanzi, G | Articolo su rivista | |
1-gen-2007 | Targeted therapy of breast cancer. | Longo, R; Torino, F; Gasparini, G | Articolo su rivista | |
1-gen-2008 | Prognostic and Predictive Significance of Surrogate Biomarkers of Angiogenesis. | Longo, R; Torino, F; Gasparini, G | Contributo in libro | |
1-gen-2008 | Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all? | Bazuro, G; Torino, F; Gasparini, G; Capurso, L | Articolo su rivista | |
1-gen-2008 | Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy | Prete, S; Turriziani, M; Massara, M; De Rossi, A; Correale, P; DE VECCHIS, L; Torino, F; Bonmassar, L; Aquino, A | Articolo su rivista | |
1-gen-2009 | Is hypothyroidism a clinically relevant toxicity of tyrosine kinase inhibitors? | Torino, F; Corsello, S; Longo, R; Barnabei, A; Gasparini, G | Articolo su rivista | |
1-gen-2009 | Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. | Torino, F; Corsello, S; Longo, R; Barnabei, A; Gasparini, G | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile